Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

[1]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[2]  A. Blann,et al.  von Willebrand factor, endothelial cell damage and atherosclerosis. , 1994, European journal of vascular surgery.

[3]  F. Rosendaal,et al.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.

[4]  E. Faragher,et al.  von Willebrand factor, the endothelium and obesity. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[5]  A. Folsom,et al.  Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis , 1993, Thrombosis and Haemostasis.

[6]  J. Vandenbroucke,et al.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. , 1993, Archives of internal medicine.

[7]  J. Miletich,et al.  Inherited predisposition to thrombosis , 1993, Cell.

[8]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Reitsma,et al.  Citations from the Literature , 2003 .

[10]  K. Titani,et al.  Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. , 1992, The Journal of biological chemistry.

[11]  H. Büller,et al.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.

[12]  A. Hofman,et al.  Haemophilia protects against ischaemic heart disease: a study of risk factors , 1990, British journal of haematology.

[13]  J. O'brien.  Blood group, von Willebrand's factor and heart disease. , 1990, Thrombosis research.

[14]  E. Briët,et al.  Bleeding time, blood groups and von Willebrand factor , 1989, British journal of haematology.

[15]  J. Vandenbroucke,et al.  Mortality and causes of death in Dutch haemophiliacs, 1973–86 , 1989, British journal of haematology.

[16]  W. Marks,et al.  The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.

[17]  G. Raskob,et al.  Epidemiology and pathogenesis of venous thrombosis. , 1986, Journal of the American College of Cardiology.

[18]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[19]  W. Somerville.  Anticoagulants and Myocardial Infarction: a Reappraisal , 1986 .

[20]  H. Rus,et al.  Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction. , 1983, Thrombosis research.

[21]  P. McKee,et al.  Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor. , 1979, Journal of Biological Chemistry.

[22]  I. Sussman,et al.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. , 1977, The Journal of clinical investigation.

[23]  J. Medalie,et al.  Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. , 1971, The New England journal of medicine.

[24]  K. Kingsbury.  Relation of ABO blood-groups to atherosclerosis. , 1971, Lancet.

[25]  M. Langman,et al.  ABO blood-groups and venous thromboembolic disease. , 1970, Lancet.